NGM BIOPHARMACEUTICALS INC Insider Trading for July 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NGM BIOPHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NGM BIOPHARMACEUTICALS INC for July 2019.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 31 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.91 | 8,855 | 123,195 | 15,931,727 | 15.9 M to 15.9 M (+0.06 %) |
Jul 31 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.58 | 19,201 | 260,727 | 15,922,872 | 15.9 M to 15.9 M (+0.12 %) |
Jul 31 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.91 | 8,855 | 123,195 | 2,362,636 | 2.4 M to 2.4 M (+0.38 %) |
Jul 31 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.58 | 19,201 | 260,727 | 2,353,781 | 2.3 M to 2.4 M (+0.82 %) |
Jul 31 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.91 | 8,855 | 123,195 | 16,121,727 | 16.1 M to 16.1 M (+0.05 %) |
Jul 31 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.58 | 19,201 | 260,727 | 16,112,872 | 16.1 M to 16.1 M (+0.12 %) |
Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.59 | 30,059 | 408,634 | 2,334,580 | 2.3 M to 2.3 M (+1.30 %) |
Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.37 | 30,753 | 411,294 | 2,304,521 | 2.3 M to 2.3 M (+1.35 %) |
Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.51 | 29,054 | 392,502 | 2,273,768 | 2.2 M to 2.3 M (+1.29 %) |
Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.59 | 30,059 | 408,634 | 16,093,671 | 16.1 M to 16.1 M (+0.19 %) |
Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.37 | 30,753 | 411,294 | 16,063,612 | 16 M to 16.1 M (+0.19 %) |
Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.51 | 29,054 | 392,502 | 16,032,859 | 16 M to 16 M (+0.18 %) |
Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.59 | 30,059 | 408,634 | 16,093,671 | 16.1 M to 16.1 M (+0.19 %) |
Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.37 | 30,753 | 411,294 | 16,063,612 | 16 M to 16.1 M (+0.19 %) |
Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.59 | 30,059 | 408,634 | 15,903,671 | 15.9 M to 15.9 M (+0.19 %) |
Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.51 | 29,054 | 392,502 | 16,032,859 | 16 M to 16 M (+0.18 %) |
Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.37 | 30,753 | 411,294 | 15,873,612 | 15.8 M to 15.9 M (+0.19 %) |
Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.51 | 29,054 | 392,502 | 15,842,859 | 15.8 M to 15.8 M (+0.18 %) |
Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.59 | 30,059 | 408,634 | 15,903,671 | 15.9 M to 15.9 M (+0.19 %) |
Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.37 | 30,753 | 411,294 | 15,873,612 | 15.8 M to 15.9 M (+0.19 %) |
Jul 26 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.51 | 29,054 | 392,502 | 15,842,859 | 15.8 M to 15.8 M (+0.18 %) |
Jul 23 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.35 | 30,760 | 410,535 | 16,003,805 | 16 M to 16 M (+0.19 %) |
Jul 23 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.54 | 30,760 | 416,337 | 15,973,045 | 15.9 M to 16 M (+0.19 %) |
Jul 23 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.99 | 6,222 | 87,043 | 15,942,285 | 15.9 M to 15.9 M (+0.04 %) |
Jul 23 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.35 | 30,760 | 410,535 | 15,813,805 | 15.8 M to 15.8 M (+0.19 %) |
Jul 23 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.54 | 30,760 | 416,337 | 15,783,045 | 15.8 M to 15.8 M (+0.20 %) |
Jul 23 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.99 | 6,222 | 87,043 | 15,752,285 | 15.7 M to 15.8 M (+0.04 %) |
Jul 23 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.35 | 30,760 | 410,535 | 2,244,714 | 2.2 M to 2.2 M (+1.39 %) |
Jul 23 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.54 | 30,760 | 416,337 | 2,213,954 | 2.2 M to 2.2 M (+1.41 %) |
Jul 23 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.99 | 6,222 | 87,043 | 2,183,194 | 2.2 M to 2.2 M (+0.29 %) |
Jul 17 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.86 | 3,900 | 54,055 | 15,936,063 | 15.9 M to 15.9 M (+0.02 %) |
Jul 17 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.69 | 16,188 | 221,547 | 15,932,163 | 15.9 M to 15.9 M (+0.10 %) |
Jul 17 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.86 | 3,900 | 54,055 | 15,746,063 | 15.7 M to 15.7 M (+0.02 %) |
Jul 17 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.69 | 16,188 | 221,547 | 15,742,163 | 15.7 M to 15.7 M (+0.10 %) |
Jul 17 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.86 | 3,900 | 54,055 | 2,176,972 | 2.2 M to 2.2 M (+0.18 %) |
Jul 17 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.69 | 16,188 | 221,547 | 2,173,072 | 2.2 M to 2.2 M (+0.75 %) |
Jul 15 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.88 | 21,014 | 291,765 | 15,725,975 | 15.7 M to 15.7 M (+0.13 %) |
Jul 15 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.87 | 10,870 | 150,752 | 15,704,961 | 15.7 M to 15.7 M (+0.07 %) |
Jul 15 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.88 | 21,014 | 291,765 | 2,156,884 | 2.1 M to 2.2 M (+0.98 %) |
Jul 15 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.87 | 10,870 | 150,752 | 2,135,870 | 2.1 M to 2.1 M (+0.51 %) |
Jul 15 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.88 | 21,014 | 291,765 | 15,915,975 | 15.9 M to 15.9 M (+0.13 %) |
Jul 15 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.87 | 10,870 | 150,752 | 15,894,961 | 15.9 M to 15.9 M (+0.07 %) |
Jul 15 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.88 | 21,014 | 291,765 | 15,915,975 | 15.9 M to 15.9 M (+0.13 %) |
Jul 15 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.87 | 10,870 | 150,752 | 15,894,961 | 15.9 M to 15.9 M (+0.07 %) |